Sponsored by:

The American Society of Hypertension, Inc.

ASH | May 19-22, 2012

ASH 2012 - New York
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Thursday May 24 2012

  • Novel Diabetes Drug Lowers Blood Pressure

    NEW YORK CITY — An investigational glucagon-like peptide-1 agonist significantly reduced systolic blood pressure in patients with type 2 diabetes who were taking oral anti-hyperglycemic medications, a phase II trial showed.

  • Low BP Not Always Good Thing Late in Life

    NEW YORK CITY — For those who had hypertension in middle age, low blood pressure later in life was linked to brain atrophy, a study conducted in Iceland showed.

Wednesday May 23 2012

  • Chronically Ill Vets Live Longer by Staying Fit

    NEW YORK CITY — Keeping fit appears to lower the mortality risk for male veterans with chronic health problems, two studies showed.

  • Thiazides Best Only for Obese Hypertensives

    NEW YORK CITY — Hypertensive patients who have a normal weight or who are overweight — but not obese — appear to be better off on a non-diuretic-based regimen, a prespecified analysis of the ACCOMPLISH trial showed.

Tuesday May 22 2012

  • Foreign-Born in U.S. Report Less Hypertension

    NEW YORK CITY — Among adults living in the U.S., those who were born in other countries were less likely to report having hypertension than were native-born Americans, researchers found.

  • Women May Need Lower Ambulatory BP Cutoffs

    NEW YORK CITY — The ambulatory blood pressure monitoring cutoff for the diagnosis of hypertension should be lower in women than in men, a researcher suggested here.

Monday May 21 2012

  • One Agent Better for RAS Blockade

    NEW YORK CITY — The use of two agents to block the renin-angiotensin system (RAS) — as opposed to one — appears to have little benefit and has significant negative effects, a meta-analysis showed.

Sunday May 20 2012

  • Lower Death Risk Seen in Resistant Hypertension

    NEW YORK CITY — Patients with hard-to-treat, resistant hypertension have greater risks of several outcomes, with the exception of all-cause mortality, researchers found.

  • Docs May Not Always Adjust Meds for Hypertension

    NEW YORK CITY — Clinical inertia among physicians is common in patients with hypertension, particularly those who are at highest risk for poor outcomes, researchers found.

Friday May 18 2012

  • Heart Is Focus for Hypertension Meeting

    NEW YORK CITY — Hypertension specialists will take a closer look at the connection between high blood pressure and the cardiovascular system at this year's meeting of the American Society of Hypertension here, according to the chair of the scientific program committee.